Introduction of Japan’s bioeconomy strategy and Japan’s leading biocommunity, one of which is Greater Tokyo Biocommunity (GTB). contents: Japan’s Bioeconomy Strategy -Global Trends, Japan’s Bioeconomy Strategy, Bio-Based Market, Japan’s Leading Biocommunity, Data Linkage Greater Tokyo Biocommunity (GTB) -Potential of Tokyo Area, Bio-innovation Promotion Areas, GTB Council, Goal and Approaches, KPI, Typical Progress, Tools for sharing activities For details, please see the documents below. Documents

Japan Bioindustry Association (JBA) and NPO Kinki Bio-Industry Development Organization (KBDO) jointly publish and manage “Japanese Life Science Startup List,” a database to introduce the activities of various types of Japanese life science startups. Currently, 225 and 140 startups are included in the Japanese and English pages of the database, respectively. The English page is available at: https://area34.smp.ne.jp/area/table/5697/FDN_H3/M?S=lbsfn2mbnak. If you are interested in biotech startups or looking for novel life science technologies or biotech products, please take a look at our list.

As stated in the Master Activity Plan, GTB has set the growth indicators (KPIs) to visualize the results of its activities. The prime KPI is the total sales of member companies of the five biotechnology-related organizations in the GTB area (listed companies and non-listed companies for which sales figures are available; hereinafter referred to as “member companies”), with the goal of expanding total sales from 102 trillion yen in FY2020 to 145 trillion yen by 2030 through annual growth of 3.6% (*The current status and target figures have been slightly revised due to the recalculation.). Here, we are pleased to announce that we have calculated the figures as of FY2021.